We found that colorectal cancer mice treated with neutralizing anti-GCSF Abs showed reduced Neut/MDSCs in multiple compartments, and an increase in colon-resident B cells and CD8+ T cells, suggesting a favorable immune environment. Here, CD8A is linked to colorectal cancer.